Document:

<PAGE>

                                                                EXHIBIT 10.32

CONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR CERTAIN REDACTED PROVISIONS OF
THIS AGREEMENT. THE REDACTED PROVISIONS ARE IDENTIFIED BY THREE ASTERISKS
ENCLOSED BY BRACKETS AND UNDERLINED. THE CONFIDENTIAL PORTION HAS BEEN FILED
SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION

                          LABORATORY SERVICES AGREEMENT
                                 BY AND BETWEEN
                          SPECIALTY LABORATORIES, INC.
                                       AND
                               UNILAB CORPORATION

                                                                October 15, 1999

<PAGE>

1.   GENERAL

     When signed, this document dated this 15th day of October 1999 constitutes
     an Agreement between SPECIALTY Laboratories, Inc. ("SPECIALTY") with its
     principal office located in Santa Monica, California and Unilab Corporation
     ("Unilab") with principal offices located in Tarzana, Sacramento, and San
     Jose, California. All terms and conditions apply to all three (3) sites
     with individual differences applicable only to the implementation dates of
     fee schedules in Attachment A.

2.   TERM AND TERMINATION

     2.1  This Agreement shall commence on October 18, 1999 and continue for
          a three (3) year period or until terminated in accordance with this
          Agreement. In consideration for Unilab's Agreement to enter into a
          three-year term,

          (a)  [***]*;

          (b)  [***]*.

     2.2  TERMINATION WITH CAUSE. Either party may terminate this Agreement with
          cause upon thirty (30) days' notice to the other party. "Cause" is
          hereby defined as a material breach by either party to comply with any
          of the terms of this Agreement after thirty (30) days written notice
          of such failure or violation by the other party giving notice of such
          default or non-compliance and written notice of its intention to so
          terminate unless within such sixty (60) day period the defaulting
          party has cured the default.

     2.3  RENEWAL. Upon expiration, this Agreement [***]*

3.   [***]*

     During the term of this Agreement, Unilab shall send to SPECIALTY for
     testing [***]*, providing that SPECIALTY offers and desires to perform such
     tests for Unilab. The test mix shall be in the same ratio, except in those
     circumstances where such tests are no longer sent out [tests are conducted
     in-house], as in the base period of August, 1999, and [***]* is
     substantially the same ratio as set forth on Attachment B.

     Notwithstanding the foregoing, effective upon a change of control of Unilab
     (as defined in Section 17), or the purchase by Unilab of a Licensed
     Clinical Laboratory with a test menu materially broader than that of
     Unilab, the [***]* shall require Unilab to send to SPECIALTY for testing
     [***],* provided however that SPECIALTY makes a commercially

-----------
     * PORTIONS OF THIS PAGE HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR
CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION.

                                     Page 2

<PAGE>

     reasonable effort to [***]*. The test mix shall be in the same ratio,
     except in those circumstances where such tests are no longer sent out
     [tests are conducted in-house], as in the base period of August 1999, and
     [***]* is in substantially the same ratio as set forth on Attachment B.

4.   LICENSURE AND ACCREDITATION

     SPECIALTY is a duly licensed independent clinical laboratory and fully
     accredited by the College of American Pathologists and CLIA, among other
     certifying agencies. SPECIALTY agrees to maintain such licensure and
     accreditation during the term of this Agreement. SPECIALTY shall maintain
     at all times during the term of this Agreement, appropriate professional
     liability coverage.

5.   SUPPLIES

     SPECIALTY shall provide, at no cost to Unilab, all necessary supplies for
     the proper preparation and submission of specimens to SPECIALTY.

6.   COURIERS AND LOGISTICS

     SPECIALTY will provide all courier and logistic services required to
     adequately address the laboratory testing submitted by three Unilab
     locations; Tarzana, San Jose, and Sacramento.

7.   [***]*

     In accordance with this Agreement, [***]*, as set forth in Attachment A.
     [***]*

8.   INVOICE

     SPECIALTY shall bill Unilab directly, on a monthly basis for its reference
     testing services except [***]*. All bills to Unilab shall be submitted
     [***]*. Unilab shall be responsible for any and all taxes (city, state,
     etc.) arising as a result of this agreement. SPECIALTY shall submit
     invoices electronically to Unilab. SPECIALTY shall make a commercially
     reasonable effort to: indicate when [***]* through the identification, of
     date of service due to the provisions in sections 10.1, 10.2, 10.3, and
     itemize [***]*.

9.   PAYMENT TERMS

     Unilab agrees to pay SPECIALTY within thirty (30) days of the date invoice
     is received by Unilab.

-----------
     * PORTIONS OF THIS PAGE HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR
CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION.

                                     Page 3

<PAGE>

10.  [***]*

     10.1 With respect to [***]*. SPECIALTY will keep all such information
          confidential except as required in the normal course of business or as
          may be required by law.

     10.2 [***]*

     10.3 [***]*

11.  COMPLIANCE POLICIES

     Both Unilab and SPECIALTY agree to comply with all applicable regulatory
     agencies including, but not limited to CLIA and HCFA. In addition, each
     party shall administer compliance policies throughout their respective
     organizations to ensure that such compliance is assured. Examples of such
     policy topics would include, but not be limited to, patient
     confidentiality, diagnosis coding, anti-kickback statutes, professional
     courtesy, Advanced Beneficiary Notice, and CPT-4 coding.

12.  SELF-REFERRAL

     In the event Unilab shall have any physician owners, and is required under
     applicable law to disclose such ownership. Unilab shall notify SPECIALTY of
     such fact so that the parties can ensure compliance with self-referral
     restrictions under applicable federal and state law.

13.  CHANGE IN RULES AND REGULATIONS

     In the event that any Medicare or Medicaid law, rules, regulations, policy
     (or any other federal, state or local law, rule, regulation, policy, or any
     interpretation thereof) at any time during the term of this agreement
     prohibits, restricts or has a materially adverse effect on the Agreement,
     then the parties to this agreement shall negotiate in good faith to amend
     or terminate the Agreement.

14.  INDEPENDENT CONTRACTOR

     At all times relevant hereto SPECIALTY shall function as an independent
     contractor rendering services to Unilab. SPECIALTY shall not be an employee
     or agent of Unilab and shall not be entitled to any employee benefits from
     Unilab.

15.  RECORDS

     15.1 Both parties agree to retain, and make available to the other party
          upon reasonable request, at their own expense for a period of four (4)
          years following the furnishing of services under this Agreement itself
          and all books, documents and records that are necessary to verify the
          nature and extent of the costs thereof, as

-----------
     * PORTIONS OF THIS PAGE HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR
CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION.

                                     Page 4

<PAGE>

          mandated by the Secretary of Health and Human Services, the
          Comptroller General of the United States or any of their duly
          authorized representatives, in a manner that complies with the
          requirements of Section 1861(v)(1)(I) of the Social Security Act and
          any regulations promulgated thereto. Unilab agrees to make available
          to SPECIALTY upon reasonable request at their own expense during the
          term of this contract, all books, documents and records that are
          necessary to verify the accuracy of billing, payor, and test mix
          accuracy.

     15.2 Both parties agree to notify the other party upon receipt of any such
          request, related to this Agreement, from any representative of the
          Secretary of Health and Human Services or the Comptroller General.

     15.3 Both parties agree that any subcontracts with related parties
          involving costs of Ten Thousand Dollars ($10,000) or more during any
          twelve (12) months period for the performance of duties under this
          Agreement shall be amended immediately to require of said related
          parties the same duties. As used herein, the term "related party"
          means any party owned or controlled by either party or with whom
          either party is to a significant extent associated or affiliated.

16.  INDEMNIFICATION

     Each party agrees to indemnify, and hold harmless, the other party's
     directors, officers, employees, and agents from and against any and all
     claims, actions, or liabilities of any nature which may be assessed against
     them by third parties in connection with the performance of services under
     this Agreement, except to the extent of any willful misconduct or gross
     negligence of the party seeking indemnification.

17.  BINDING AFFECT & ASSIGNMENT

     This Agreement shall be binding upon and inure to the benefit of the
     parties hereto and their respective successors and assigns provided,
     however that this Agreement may not be transferred or assigned without the
     expressed written consent of SPECIALTY, except for the pending transaction
     with Kelso, which is specifically deemed to have been consented to by
     SPECIALTY.

     The parties hereto agree that except for the Kelso transaction, a change of
     control of Unilab shall constitute an assignment of this Agreement. For
     purposes of this Agreement, change of control means the acquisition of
     Unilab by any person, group or entity by means of any transaction or series
     of related transactions (including, without limitation, any reorganization,
     merger or consolidation, but excluding any merger effected exclusively for
     the purpose of changing the domicile of Unilab) in which Unilab's
     shareholders of record as constituted immediately prior to such acquisition
     will, immediately after such acquisition, hold less than fifty percent
     (50%) of the voting power of the surviving or acquiring entity; or a sale
     of all or substantially all of the assets of Unilab in a transaction in
     which Unilab's shareholders of record as constituted immediately prior to
     such sale will immediately after such sale, hold less than 50% of the
     voting power of the surviving or acquiring entity.

                                     Page 5

<PAGE>

18.  FORCE MAJEURE

     SPECIALTY shall not be liable for any failure to perform its duties under
     this Agreement due to acts of God; acts, regulations or laws of any
     government; war or any other condition or cause beyond SPECIALTY's
     reasonable control. However, if circumstances prevent SPECIALTY from
     performing its duties, SPECIALTY agrees to use its commercially reasonable
     efforts to facilitate transfer of testing to an alternative laboratory as
     mutually agreed.

19.  GOVERNING LAWS

     This Agreement shall be governed and construed in accordance with the laws
     of the State of California.

20.  ATTORNEY'S FEE/COSTS

     SPECIALTY and Unilab hereby agree that if any action, suit or proceeding is
     filed by either party to enforce the terms of this Agreement, the
     prevailing party shall be entitled to its actual attorney's fees and costs
     in initiating and/or prosecuting said action, suit or proceeding.

21.  VENUE

     21.1 Unilab agrees and specifically acknowledges that all of the services
          undertaken and/or performed by SPECIALTY are rendered from California.

     21.2 Unilab agrees that if any actions are to be brought by either
          SPECIALTY and/or Unilab, that said action, suit or proceeding shall be
          filed in the Los Angeles Superior Court or Los Angeles Municipal
          Court. Unilab HEREBY AGREES AND SUBMITS TO PERSONAL JURISDICTION IN
          LOS ANGELES COUNTY.

22.  CONFIDENTIALITY

     Neither party will disclose this Agreement or any of its terms or
     conditions to any third party except as and to the extent that such
     disclosure may be required by law, and except that either party may make
     disclosure to its lenders or investors or to potential buyers if such
     lenders, investors and potential buyers execute and deliver to both parties
     confidentiality agreements reasonably satisfactory to both parties. Each
     party agrees to hold in strictest confidence, and not disclose, divulge or
     communicate to, or use for the benefit or, any other person, corporation or
     entity, or misuse in any way, and confidential or non-public information of
     the other party, other that the disclosure, divulgence or communication of
     such confidential or non-public information or trade secret that may be
     required by applicable law.

23.  NOTICES

     All notices to be given by one party to the other under this Agreement
     shall be given in writing, mailed or delivered as follows:

                                     Page 6

<PAGE>

     Unilab:       Unilab Corporation
                   18408 Oxnard Street
                   Tarzana, California 91356
                   Attention:

     SPECIALTY:    SPECIALTY Laboratories, Inc.
                   2211 Michigan Avenue
                   Santa Monica, California 90404
                   Attention: Contract Administration

24.  ENTIRE AGREEMENT

     This agreement contains the entire understanding between the parties hereto
     and supersedes any and all prior Agreements and arrangements between the
     parties relating to the subject matter hereof. No amendment, change,
     modification or alteration of the terms and conditions hereof shall be
     binding unless in writing.

                                     Page 7

<PAGE>

FOR:                                   ACCEPTED:

SPECIALTY LABORATORIES, INC.           UNILAB CORPORATION
SANTA MONICA, CALIFORNIA               TARZANA, CALIFORNIA

NAME:       Paul F. Beyer              NAME:
     ----------------------------           ----------------------------

SIGNATURE:  /s/ Paul F. Beyer          SIGNATURE:          /s/
          -----------------------                -----------------------

TITLE:      President                  TITLE:       Vice President
      ---------------------------            ---------------------------

DATE:       10/15/99                   DATE:        10/15/99
     ----------------------------           ----------------------------

Please mail the signed Agreements to:

         Specialty Laboratories, Inc.
         2211 Michigan Avenue
         Santa Monica, California 90404-3900
         Attention: Contract Administration

                                     Page 8<PAGE>

                                                                   Exhibit 10.20

                     THIRD AMENDMENT TO MANAGEMENT AGREEMENT

     THIS AMENDMENT TO MANAGEMENT AGREEMENT (this "Agreement") is made and
entered into as of July 30, 1999 (the "Effective Date") between Coventry
Industries Corp., a Florida corporation, whose principal place of business is
1900 Corporate Blvd, Suite 400 East, Boca Raton, Florida 33431 (the "Company"),
and Robert Hausman, an individual whose address is 3785 NW 65th Lane, Boca
Raton, Florida 33496 (the "Manager").

RECITALS

     WHEREAS, the Company and Hausman are parties to that certain Management
Agreement dated as of July 1, 1997 and amended as of November 1, 1997 and
December 1, 1998, copies of which are attached hereto as Exhibit A and
incorporated herein by such reference (the "Management Agreement").

     WHEREAS, the parties wish to amend certain specific terms of the Management
Agreement as herein after set forth.

     NOW, THEREFORE, in consideration of the mutual agreements herein made, the
Company and the Manager do hereby agree as follows:

     1. The Executive shall serve as the President of the Company and shall be
responsible for all tasks and activities that are customarily the responsibility
of such officer and all tasks and activities reasonably determined by the Board
of Directors of the Company. The Executive shall continue to serve on the Board
of Directors of the Company or any committee thereof without additional
compensation.

     2. Paragraph 3. of the agreement as written in the second amendment shall
be deleted and substituted as follows:

     3. Compensation and Benefits. (a) As his sole compensation payable by the
Company under this Agreement, the Manager shall be entitled to receive the
following:

          (1) an annual management fee of one hundred thirty one thousand
     ($131,000) dollars, payable in twelve equal monthly installments, with an
     annual incremental increases of the greater of (i) the percentage increase
     in the Consumer Price Index, all items, as published by the United States
     Department of Labor, since the date of this Agreement (in the case of the
     first annual increase) or since the most recent anniversary of the date of
     this Agreement (in the case of all subsequent annual increases), or (ii)
     six percent (6%) of the previous year's base management fee. This increase
     will be effective on January 1st of each year of the management agreement.

          (2) a car allowance of $1,500 per month to cover the cost of Manager's
     automobile and operating expenses;

          (3) to participate in any hospitalization or disability insurance
     plans, health programs, pension plans, bonus plans or similar benefits that
     may be available to other executives of the Company (including coverage
     under any officers and directors liability insurance policy);

                                      -1-
<PAGE>

          (4) such other compensation, including, without limitation, bonus
     compensation, as may be determined by a majority of the Company's Board of
     Directors, in their sole discretion.

          (5) as consideration for the elimination of the 3% Net Pre-Tax Income
     cash bonus and the stock options granted in the prior agreements, manager
     hereby is granted 50,000 shares of the Company's common stock as
     compensation for such consideration.

          (b) The Manager shall be reimbursed for all reasonable expenses
incurred in the rendering of the services hereunder.

          3. Paragraph 5 of the agreement as written in the second amendment
shall be deleted and substituted as follows:

     5. Repayment of Loans, Accrued Dividends and Accrued Salary. As of the date
of this Agreement, Manager is owed approximately $400,000 consisting of accrued
salary, accrued dividends, accrued interest and loans to the Company. In order
to repay such amount as promptly as practicable, the Company will issue a note
(the "Note") to Manager. The Note will have the following terms:

          (1) bear interest at 8% per annum,

          (2) provide for a minimum of 24 equal monthly installments of
     principal and interest that are payable in cash commencing August 1st,
     1999. The Company, at it's option, may extend repayment of this notes up to
     an additional 24 months if the cash flow requirements necessitate such
     extension. The notes may be prepaid at any time without penalty.

          (3) provide for acceleration upon the termination of this Agreement
     without cause.

          (4) Provide that if the manager is disabled, dies, is terminated with
     cause, or the management agreement is not renewed, that the remaining
     balance due on the note will be paid to the manager or manager's successors
     or heirs in accordance with the terms outlined in (2) above.

          4. Paragraph 6 of the agreement as written in the second amendment
shall be deleted and substituted as follows:

          6.   Redemption of Preferred Stock. (a) Manager and Manager's wife own
               14,375 shares of the Company's Series E Preferred Stock (the
               "Preferred Stock"). Manager and the Company have agreed that the
               Preferred Stock will be exchanged for 143,750 shares of Common
               Stock, of which 75,000 shares has been exchanged in conjunction
               with the closing of the BSD transaction and the remaining 68,750
               shall be exchanged prior to the closing of the People First
               transaction. Effective on such exchange, the Management Fee
               payable pursuant to Section 3(1) above will be increased by
               $77,000, which amount is equal to the dividends on the Preferred
               Stock. The Company and Manager agree to facilitate the sale of
               these shares of Common Stock and Manager will use the proceeds of
               such sales to repay principal and interest on the Manager's loan
               from Chase Manhattan Bank in the approximate principal amount of
               $1,115,000 (the "Loan"). The Company agrees that any shortfall
               from the sale of stock will be compensated with additional shares
               or cash in order to pay off in full the loan from Chase. The
               management fee shall be reduced pro rata as Manager receives
               funds from the Company with respect to the sale of Common Stock
               and the interest payments decrease.

                                      -2-
<PAGE>

          5. Manager and the Company agree not to invoke the "change in control"
provisions of Section 4 as a result of the transactions set forth in the
Exchange Agreement dated as of September 30, 1998.

          6. Paragraphs 5 through 17 shall be renumbered to be 7 through 19. The
remaining terms and conditions of the Management Agreement remain in full force
and effect.

     IN WITNESS WHEREOF, the parties have executed this Agreement as of the date
first above written in Boca Raton, Florida.

                                            COVENTRY INDUSTRIES CORP.

                                            By: _____________________________
                                            Name:
                                            Title:

                                            MANAGER

                                            ----------------------------
                                            Robert L. Hausman

                                      -3-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00016-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00016-of-00352.parquet"}]]